Pharmacy

Below are 11 legal actions involving members of the drug supply chain, including pharmaceutical manufacturers, pharmacy benefit managers, pharmacies, pharmacists and distributors, reported by Becker's Hospital Review in the last two weeks.

Medicare covered 30 percent of prescription drug costs, or $101 billion, in 2017, according to a new Kaiser Family Foundation study.

Private health insurers covered the largest share of prescription drug costs, $140 billion, in 2017, according to a new Kaiser Family Foundation study.

Eli Lilly & Co.'s lower-priced authorized generic version of Humalog, an insulin injection, is now available for order in pharmacies, the drugmaker announced May 22.

Managing drug shortages has become increasingly challenging for hospitals and health systems.

Ireland-based drug company Mallinckrodt sued HHS and CMS May 21 over a regulatory move that would change Medicaid rebates for its Acthar Gel, a best-selling injection for multiple sclerosis, lupus and other ailments, according to The Wall Street Journal.

Since July 2018, there have been a string of recalls related to three common generic heart drugs — losartan, irbesartan and valsartan — due to the detection of probable human carcinogens.

Baltimore officials sued a subsidiary of Johnson & Johnson, accusing the drugmaker of using "sham" patent litigation to delay the launch of lower-cost generics and forcing the city to needlessly spend millions of dollars on the medication, according to a…

Data analytics can be leveraged to address various challenges in the pharmacy industry, from drug shortages to identifying high-risk readmissions.

As hospitals face the dual pressure of improving patient satisfaction and lowering costs, they are increasingly turning to their pharmacies for help on both fronts.